The Global Health Exhibition at the Riyadh International Convention and Exhibition Center in Malham has unveiled significant health sector investments and projects totaling more than SAR55 billion and major agreements reached between leading companies in the sector. The main investments included the Dr. Sulaiman Al-Habib Medical Group's announcement of new healthcare projects valued at over SAR10 billion, the establishment of Dallah Hospital in Riyadh for SAR4 billion, and expansion initiatives by Fakeeh Care Group worth SAR5 billion. The investments aim to support the objectives of Saudi Arabia's Vision 2030 health sector transformation program, focusing on enhancing healthcare quality and accessibility. Key partnerships highlighted during the forum included agreements with the National Unified Procurement Company for Medical Supplies (NUPCO), Sudair Pharmaceutical Company, and global health leaders such as Sanofi and Novo Nordisk. These partnerships will localize the production of six to seven insulin pro ducts, support health expansions valued at SAR5 billion, and fund the development of five primary care centers and two new hospitals. In line with innovation goals, the forum also introduced a robotic device for sample transfer without human intervention and a specialized vascular surgery device aimed at enhancing surgical precision and speed. These initiatives align with the Ministry of Health's objectives under the transformation program to bolster drug and health security, provide sustainable and integrated healthcare services, increase readiness to address health challenges, and achieve self-sufficiency in medicine and medical supply production. Source: Saudi Press Agency